文献速递多重用药认知障碍与谵妄

Shed-MEDS减药方案在辅助生活机构痴呆患者中的试点实施

Pilot Implementation of the Shed-MEDS Deprescribing Intervention for Persons With Dementia in Assisted Living Facilities.
PubMed 文献 · J Am Med Dir Assoc · 2026-07-04

本研究在2家记忆照护辅助生活机构开展单臂试点干预,由执业护士主导依据Shed-MEDS方案为痴呆患者减药。18例入组、16例完成干预和90天随访,结果显示总用药数显著减少(平均差9),潜在不适当用药有减少趋势(平均差5.5),生活质量改善(94-104.5)。

要点

  • 执业护士主导的减药干预在辅助生活机构记忆照护中可行。
  • 90天随访总用药数平均减少9种,潜在不适当用药呈减少趋势。
  • 代理评估的生活质量从94改善至104.5。

核心结论

  • 执业护士主导的Shed-MEDS减药干预在辅助生活机构记忆照护中使总用药数减少并改善生活质量。
  • 仍需更大规模研究评估该干预在辅助生活机构记忆照护中的有效性。

研究设计与样本

  • 单臂试点干预研究,在2家记忆照护辅助生活机构开展。
  • 纳入65岁及以上、诊断为痴呆且用药≥5种或存在1种潜在不适当用药的居民,共18例入组、16例完成干预和90天随访。
  • 由研究执业护士审查用药记录识别可减药物,经代理同意后与主要处方者沟通并由执业护士协调辅助生活机构医疗团队最终确定减药计划。

主要发现

  • 入组时每例中位用药数为13种,其中中位潜在不适当用药为7种。
  • 执业护士平均每例推荐减药8种,代理同意79%的推荐,处方者同意86%的共享推荐。
  • 90天随访时总用药数显著减少(平均差9),潜在不适当用药呈减少趋势(平均差5.5),生活质量改善(94-104.5)。
  • 完成干预和随访的16例中多数为女性(64.7%),中位年龄82岁。

临床怎么用

  • 在辅助生活机构记忆照护中,可由执业护士依据Shed-MEDS方案主导用药审查并与代理及处方者协作推进减药。

局限性

  • 为单臂试点研究,样本量小(18例入组、16例完成),仅涉及2家记忆照护辅助生活机构。
  • 潜在不适当用药的减少仅为趋势,未达到显著。
  • 需要更大规模研究评估该干预的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: A nurse practitioner (NP)-led intervention aimed to safely reduce the total number of medications and potentially inappropriate medications (PIMs) for persons living with dementia using the Shed-MEDS deprescribing protocol. DESIGN: Single-arm pilot intervention study in 2 memory care assisted living facilities (ALFs). METHODS: Residents aged 65 or older with a diagnosis of dementia and taking 5 or more medications or 1 PIM were eligible for participation. Surrogates provided consent and completed standardized assessments at enrollment and 90-day follow-up. Quality of life was measured via the proxy-rated Dementia Quality of Life Instrument. The study NP conducted a medication review via each participant's medication administration record to identify potential medications for deprescribing. Deprescribing recommendations were discussed with the participant's surrogate, and if the surrogate agreed, recommendations were shared with the primary prescriber to assess their agreement. After discussion with the primary prescriber, the study NP coordinated with the ALF medical team to finalize a deprescribing plan. RESULTS: Of 18 enrolled persons living with dementia, 16 completed the intervention and follow-up; the majority were female (64.7%) with a median age of 82 years. The median number of medications per participant at enrollment was 13, including 7 PIMs. The NP recommended, on average, 8 medications per participant for deprescribing, and surrogates agreed with 79% of recommendations. Prescribers agreed with 86% of shared deprescribing recommendations. By 90-day follow-up, there was a significant reduction in total medications (mean difference, 9) and a trend toward fewer PIMs (mean difference, 5.5), with an improvement in quality of life (94-104.5). CONCLUSIONS AND IMPLICATIONS: A pilot implementation of an NP-led deprescribing intervention in ALF memory care resulted in fewer medications and improvement in quality of life. A larger study is needed to evaluate the efficacy of NP-led deprescribing interventions in ALF memory care settings.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kim JL, Hollingsworth EK, Bartoo C, et al. Pilot Implementation of the Shed-MEDS Deprescribing Intervention for Persons With Dementia in Assisted Living Facilities. J Am Med Dir Assoc. 2026. PMID: 42400982. doi:10.1016/j.jamda.2026.106360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。